Ketamine therapy is not appropriate for everyone, and at Valor Health Solutions, we are direct about that from the first conversation. The clinical evaluation that every patient goes through before treatment is approved exists precisely to answer this question for your specific history. Most people who contact us are appropriate candidates, but the ones who are not deserve to know that clearly rather than go through a process that was never going to be right for them.
Who Typically Qualifies
The most common candidate profile for ketamine therapy is someone with treatment-resistant depression (TRD): a documented history of major depressive disorder that has not responded adequately to at least two antidepressant medications at therapeutic doses and for a sufficient duration (National Institutes of Health). This profile is the clinical baseline because it is the condition for which the research on ketamine is most robust, and because these are patients for whom standard alternatives have genuinely run thin.
At Valor Health Solutions, we also work with patients managing PTSD and trauma, anxiety and panic disorders, OCD, bipolar depression, and suicidal ideation. Patients with chronic neuropathic pain conditions, including complex regional pain syndrome (CRPS) and fibromyalgia, may be candidates for our longer pain protocol infusions. Each of these conditions has its own clinical evidence base supporting ketamine’s use, and each requires its own assessment to determine whether treatment is appropriate.
Why Diagnosis Alone Is Not Enough
Having a diagnosis that appears on our conditions list does not automatically make someone a good candidate. Candidacy depends on a fuller picture: complete psychiatric history, medication history, the presence of any medical conditions that interact with ketamine, and what a patient’s goals for treatment actually are.
The research confirms that ketamine’s most well-documented antidepressant effects occur in patients with treatment-resistant presentations, specifically those who have already tried conventional options without adequate response (National Institutes of Health). Patients who have not yet completed first-line treatment trials may be better served by starting there. Our role is not to put every patient in the infusion chair. It is to determine whether ketamine is the most appropriate next step for each individual who comes to us.
Who May Not Be a Good Candidate
Certain medical and psychiatric histories affect candidacy. Uncontrolled hypertension, a history of psychosis, active substance use disorder, and certain cardiovascular conditions are among the factors our clinical team evaluates carefully and that may preclude treatment or require additional consultation before proceeding.
The side effect profile of IV ketamine is generally mild and brief, as documented by the National Institutes of Health. The dissociative experience during an infusion is temporary and clinically supervised. The dissociative quality of the experience does mean it is not well-suited to patients who have a significant history of severe dissociative symptoms outside of a clinical context, and this is something we discuss directly and honestly during the evaluation.
We also evaluate whether the conditions someone presents with are on the confirmed treatment list for ketamine at our clinic. We do not recommend ketamine for conditions where the clinical rationale is absent.
Anxiety, Depression, and Co-Occurring Presentations
Many patients who contact us present with both anxiety and depression rather than one or the other in isolation. Research confirms a strong bidirectional relationship between these conditions, with each frequently amplifying the other (American Journal of Psychiatry). Patients with co-occurring anxiety and depression are typically appropriate candidates for the same protocols we use for primary depression, and the evaluation looks at both dimensions of the clinical picture.
When anxiety is the predominant presenting condition and has not responded to standard care, that is a separate clinical conversation. We have it specifically rather than defaulting to a single diagnostic frame.
What the Evaluation at Valor Health Solutions Looks Like
Every patient begins with a $49 consultation, which is applied toward the first treatment if care proceeds. That initial meeting is a focused review of your medical and mental health history with one of our licensed providers. It is a clinical conversation, not a sales process. The goal is an accurate picture of your history and an honest answer about whether ketamine therapy is the appropriate next step.
If the evaluation supports moving forward, our team reviews treatment options, insurance and payment details, and scheduling with you. Financial review does not happen until after clinical approval, which means you are not managing cost questions before you know whether treatment is right for you.
We encourage every patient to come in with questions and to be as thorough as possible about their history, including the things they are uncertain about or uncomfortable discussing. The evaluation is more useful when both sides are working from the same complete information. Results vary by individual, and a thorough evaluation is the foundation for any plan that has a realistic chance of succeeding.
Frequently Asked Questions
Do I need a referral from a psychiatrist to be evaluated?
No referral is required to book a consultation at Valor Health Solutions. You can schedule directly online through our patient portal or by calling 888-214-2144. If you are a veteran seeking treatment through the VA Community Care program, that process involves a referral through your PCP or psychiatrist, and we have a detailed guide to navigating that pathway on our website.
What if I’ve only tried one antidepressant?
Two antidepressant trials at appropriate doses and durations is the general clinical threshold for a treatment-resistant designation, but it is not an absolute gate in every case. Your provider will review your history in context. If you have completed only one medication trial, the more appropriate next step may be a second trial before moving to ketamine, and we will say so directly if that is our assessment.
Can someone with a history of substance use be considered?
It depends on the nature and current status of that history. Active substance use disorder is generally a contraindication for ketamine therapy. A past history that is now in stable remission is evaluated on a case-by-case basis during the clinical assessment. This is something to discuss openly during your consultation rather than assume automatically disqualifies you.
What happens if the evaluation determines I’m not a good candidate?
We tell you clearly and explain why. If there is a different treatment or a different pathway that is more appropriate for your situation, we discuss that as well. An accurate answer, even when it is not the one a patient was hoping for, is the most useful thing we can offer. We would rather give you that information early than proceed with a treatment that is not right for your history.
Key Takeaways
- The most common candidate profile for ketamine therapy is treatment-resistant depression: inadequate response to at least two antidepressants at appropriate doses and durations.
- At Valor Health Solutions, we also treat PTSD, anxiety, OCD, bipolar depression, suicidal ideation, and chronic neuropathic pain with ketamine, subject to clinical evaluation.
- Diagnosis alone does not establish candidacy. A full clinical evaluation examining psychiatric history, medical history, and treatment goals is required before any treatment is approved.
- Certain conditions, including uncontrolled hypertension, active substance use disorder, and a history of psychosis, may preclude ketamine therapy or require additional consultation before proceeding.
- Results vary by individual. The $49 initial consultation is the starting point for an honest assessment of whether ketamine is the right next step for your situation.
The candidacy question is worth asking directly, and we are set up to answer it that way. At Valor Health Solutions, the evaluation exists to give every patient an accurate clinical answer before any commitment is made. If you are in Clearwater, FL or Johnson City, TN and want to know whether ketamine therapy makes sense for your history, call us at 888-214-2144 or book a $49 consultation through our patient portal.
References
- National Institutes of Health. Studies show ketamine produces rapid antidepressant effects in patients with treatment-resistant major depression who have not responded to other medications. https://pubmed.ncbi.nlm.nih.gov/23982301/
- National Institutes of Health. Side effects from a single antidepressant dose of intravenous ketamine are mild and brief, supporting its safety profile in clinical settings. https://www.nih.gov/news-events/news-releases/side-effects-mild-brief-single-antidepressant-dose-intravenous-ketamine
- American Journal of Psychiatry. Research confirms a strong bidirectional relationship between anxiety and depression, supporting the value of treatments that address both conditions. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030305
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a licensed medical provider with full knowledge of your medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.
